HARBINGER VENTURES
Harbinger's mission is to be a value-added venture investor in the core technologies that will enhance the productivity and experience at the workplace or at home. Leveraging the MiTAC-SYNNEX Group's strong financial backing and web of networks, they strive to create synergy and forge strategic relationships among their investee companies and the Group's affiliated companies at every opportunity. Welcoming challenge, Harbinger will continue to be a forerunner in the technologies that will change the communications and computing networks of tomorrow while generating tangible results and real value for both its investees and investors.
HARBINGER VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
2000-01-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Sectigo SSL Sectigo Domain SSL Wix Wix Forms
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-02 | Cora | Harbinger Ventures investment in Series A - Cora | 7.5 M USD |
| 2019-01-19 | Vinebox | Harbinger Ventures investment in Series A - Vinebox | 5.9 M USD |
| 2017-11-06 | Cora | Harbinger Ventures investment in Series A - Cora | 6 M USD |
| 2014-09-23 | Eureka Therapeutics | Harbinger Ventures investment in Series C - Eureka Therapeutics | 21 M USD |
| 2011-01-05 | Coda Automotive | Harbinger Ventures investment in Series D - Coda Automotive | 76 M USD |
| 2009-12-31 | Envivio | Harbinger Ventures investment in Debt Financing - Envivio | 1000 K USD |
| 2008-09-01 | Envivio | Harbinger Ventures investment in Venture Round - Envivio | 25 M USD |
| 2008-07-14 | A10 Networks | Harbinger Ventures investment in Series C - A10 Networks | 23 M USD |
| 2008-04-01 | Quintic | Harbinger Ventures investment in Series B - Quintic | N/A |
| 2008-01-01 | Crown Bioscience | Harbinger Ventures investment in Venture Round - Crown Bioscience | N/A |